About Us
Company Overview
Executive Team
Board of Directors
Contact
Science & Pipeline
Pipeline
Publications
Patients
Partners
Business Development
Media
Press Release
Careers
Corporate Culture
Job Opportunities
Investors
中文
中文
About Us
Company Overview
Executive Team
Board of Directors
Scientific Advisory Board
Contact
Science & Pipeline
Pipeline
Publications
Patients
Partners
Business Development
Media
Press Release
Media Report
Careers
Corporate Culture
Job Opportunities
Investors
Transform Deadly Cancer into a Chronic and Eventually Curable Disease
Company Overview
Executive Team
Board of Directors
Company Overview
Executive Team
Board of Directors
Scientific Advisory Board
Yang (Carsten) Lu
Hangzhou,China
CEO, Chairman of our Board of Directors
Lars E. Birgerson, MD, PhD
New Jersey, U.S.
President, Chief Medical Officer, CEO of U.S. Subsidiary
Archie Tse, MD, PhD
New Jersey, U.S.
Head of Research & Development
Wei (Vicky) Zhang, MS
Hangzhou/Hongkong,China
Chief Financial Officer
Donghui (Victor) Yang
Hangzhou,China
Co-Founder & SVP
Kaiyang (Tom) Tang
New Jersey, U.S.
SVP & Global Head of Clinical Operations
Victoria Elizabeth Demby, PhD
New Jersey, U.S.
SVP & Global Head of Regulatory Affairs
Shifeng Liu, PhD
Hangzhou,China
SVP & Global Head of CMC, Preclinical Research & Procurement
Nanhai He, PhD
New Jersey, U.S.
VP of Drug Discovery
Zhiyong Yu, PhD
Hangzhou,China
VP of Operation
Xiaofeng (Alex) Ye
New Jersey, U.S.
VP of Global Commercialization Strategy